Navigation Links
Dedication to the Medical Industry - The First International PEEK Meeting
Date:4/24/2013

Thornton-Cleveleys, UK (PRWEB) April 24, 2013

The First International PEEK Meeting will convene April 25-26 at The Union League in Philadelphia, PA. The conference provides a global forum to share leading edge research on advancements in medical grade PEEK technology and clinical applications.

Medical device designers, material scientists and clinicians specializing in biomaterials are expected to attend. Podium and poster presentations will cover a wide range of PEEK topics including: properties, test methods and processing; biocompatibility; wear properties; modifications that alter cellular reactions; biomechanical performance of devices; and clinical performance and retrieval studies of PEEK based implants.

The conference is a testament to the rate at which PEEK is becoming the preferred implant material across a growing number of medical applications. More than 35 abstracts that cover applications as diverse as posterior spinal rods, self-tapping suture anchors, joint replacement bearing surfaces and patient specific craniomaxilofacial implants were accepted for inclusion in the conference program.

This inaugural meeting is organized by the Implant Research Center at Drexel University and the engineering and scientific consulting firm Exponent and supported by Invibio® Biomaterial Solutions, the global leader of PEEK-based biomaterials to the medical device industry.

Invibio strives to advance medical device innovation through support of robust PEEK research and development programs. Invibio has been involved in many of the research projects that will be presented at the PEEK International Meeting, through collaborations with industry and academia. John Devine, the Marketing and Technology Director at Invibio comments, “Since its inception in 1999, Invibio has invested heavily in basic science and applied research related to high performance implantable polymers used in medical devices. Sponsoring the International PEEK Meeting not only gives researchers and industry a forum for sharing and discussing their research, but also gives our customers a better understanding about how new PEEK-based compounds and processing techniques can be exploited to improve upon today’s medical implants and practical advice for getting those new devices to market faster.”

More information on the event can be found at http://www.medicalpeek.org/pub_reports/view/152.

About Invibio
Invibio® is a global leader providing high performance biomaterials, advanced technical research and consultative solutions to medical device manufacturers across a wide range of markets. The company provides medical device manufacturers with PEEK-OPTIMA® polymer and compounds, MOTIS® polymer, ENDOLIGN® composite and PEEK-CLASSIX® polymer for the development of long- and short-term implantable medical devices.

For more information, please contact Invibio at: 866 468 4246 or +484 342 6004 (U.S.), +44 (0) 1253 898000 (U.K.), +852 2366 4448 (Asia Pacific) or online at http://www.invibio.com., info(at)invibio(dot)com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10666197.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstanding Shares of Common Stock of Obagi Medical Products, Inc.
2. VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
3. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
4. AFcell Medical Hires Chief Operating Officer
5. OHK Medical Devices appoints Mr. Omer Inbar as Chief Executive Officer
6. Maryville, Tennessee Based Molecular Pathology Laboratory Network (MPLN) Celebrates 38th Annual Medical Laboratory Professional Week by Honoring Employees
7. Nebraska Medical Center Implants States First SynCardia Total Artificial Heart
8. Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
9. BioClinica Releases Integrated Medical Image Management Solution
10. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
11. AtheroNova Adds New Medical Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology:
(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):